nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCC1—Dactinomycin—testicular cancer	0.113	0.144	CbGbCtD
Mifepristone—ABCC1—Epirubicin—testicular cancer	0.082	0.104	CbGbCtD
Mifepristone—ABCC1—Vinblastine—testicular cancer	0.0709	0.0899	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0661	0.0838	CbGbCtD
Mifepristone—CYP3A7—Ifosfamide—testicular cancer	0.0661	0.0838	CbGbCtD
Mifepristone—ABCC1—Etoposide—testicular cancer	0.0639	0.081	CbGbCtD
Mifepristone—CYP3A5—Ifosfamide—testicular cancer	0.0495	0.0628	CbGbCtD
Mifepristone—ABCC1—Doxorubicin—testicular cancer	0.0436	0.0553	CbGbCtD
Mifepristone—ABCC1—Methotrexate—testicular cancer	0.0422	0.0535	CbGbCtD
Mifepristone—ABCB1—Dactinomycin—testicular cancer	0.0273	0.0346	CbGbCtD
Mifepristone—PGR—corpus luteum—testicular cancer	0.0245	0.252	CbGeAlD
Mifepristone—CYP3A5—Etoposide—testicular cancer	0.0237	0.03	CbGbCtD
Mifepristone—AR—scrotum—testicular cancer	0.0213	0.219	CbGeAlD
Mifepristone—CYP3A4—Ifosfamide—testicular cancer	0.0193	0.0245	CbGbCtD
Mifepristone—ABCB1—Vinblastine—testicular cancer	0.0171	0.0217	CbGbCtD
Mifepristone—AR—seminiferous tubule of testis—testicular cancer	0.0165	0.17	CbGeAlD
Mifepristone—CYP2D6—Vinblastine—testicular cancer	0.0161	0.0204	CbGbCtD
Mifepristone—ABCB1—Cisplatin—testicular cancer	0.0157	0.0199	CbGbCtD
Mifepristone—ABCB1—Etoposide—testicular cancer	0.0154	0.0195	CbGbCtD
Mifepristone—ABCB1—Doxorubicin—testicular cancer	0.0105	0.0133	CbGbCtD
Mifepristone—CYP3A4—Vinblastine—testicular cancer	0.0102	0.013	CbGbCtD
Mifepristone—ABCB1—Methotrexate—testicular cancer	0.0102	0.0129	CbGbCtD
Mifepristone—CYP2D6—Doxorubicin—testicular cancer	0.0099	0.0126	CbGbCtD
Mifepristone—CYP3A4—Etoposide—testicular cancer	0.00923	0.0117	CbGbCtD
Mifepristone—AR—semen—testicular cancer	0.00915	0.0942	CbGeAlD
Mifepristone—CYP3A4—Doxorubicin—testicular cancer	0.0063	0.00799	CbGbCtD
Mifepristone—AR—seminal vesicle—testicular cancer	0.00194	0.02	CbGeAlD
Mifepristone—ABCC1—seminal vesicle—testicular cancer	0.00184	0.019	CbGeAlD
Mifepristone—NR3C1—embryo—testicular cancer	0.0015	0.0154	CbGeAlD
Mifepristone—PGR—female gonad—testicular cancer	0.00143	0.0147	CbGeAlD
Mifepristone—NR3C1—seminal vesicle—testicular cancer	0.0014	0.0145	CbGeAlD
Mifepristone—AR—gonad—testicular cancer	0.0014	0.0144	CbGeAlD
Mifepristone—PGR—testis—testicular cancer	0.00127	0.0131	CbGeAlD
Mifepristone—AR—female gonad—testicular cancer	0.00114	0.0117	CbGeAlD
Mifepristone—ABCC1—female gonad—testicular cancer	0.00108	0.0111	CbGeAlD
Mifepristone—NR3C1—gonad—testicular cancer	0.00101	0.0105	CbGeAlD
Mifepristone—AR—testis—testicular cancer	0.00101	0.0104	CbGeAlD
Mifepristone—ABCC1—testis—testicular cancer	0.000959	0.00988	CbGeAlD
Mifepristone—PGR—lymph node—testicular cancer	0.000919	0.00947	CbGeAlD
Mifepristone—CYP3A5—female gonad—testicular cancer	0.000831	0.00856	CbGeAlD
Mifepristone—NR3C1—female gonad—testicular cancer	0.000825	0.0085	CbGeAlD
Mifepristone—ABCB1—embryo—testicular cancer	0.000801	0.00825	CbGeAlD
Mifepristone—ABCB1—seminal vesicle—testicular cancer	0.000752	0.00775	CbGeAlD
Mifepristone—AR—lymph node—testicular cancer	0.000732	0.00754	CbGeAlD
Mifepristone—NR3C1—testis—testicular cancer	0.000732	0.00754	CbGeAlD
Mifepristone—ABCC1—lymph node—testicular cancer	0.000695	0.00716	CbGeAlD
Mifepristone—CYP2D6—female gonad—testicular cancer	0.000614	0.00632	CbGeAlD
Mifepristone—CYP2D6—testis—testicular cancer	0.000544	0.00561	CbGeAlD
Mifepristone—ABCB1—gonad—testicular cancer	0.000543	0.0056	CbGeAlD
Mifepristone—NR3C1—lymph node—testicular cancer	0.00053	0.00546	CbGeAlD
Mifepristone—ABCB1—female gonad—testicular cancer	0.000442	0.00455	CbGeAlD
Mifepristone—ABCB1—testis—testicular cancer	0.000392	0.00403	CbGeAlD
Mifepristone—Malaise—Etoposide—testicular cancer	0.000308	0.00269	CcSEcCtD
Mifepristone—Breast disorder—Methotrexate—testicular cancer	0.000307	0.00268	CcSEcCtD
Mifepristone—Decreased appetite—Ifosfamide—testicular cancer	0.000307	0.00268	CcSEcCtD
Mifepristone—Headache—Vinblastine—testicular cancer	0.000306	0.00268	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.000306	0.00267	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000305	0.00266	CcSEcCtD
Mifepristone—Body temperature increased—Dactinomycin—testicular cancer	0.000305	0.00266	CcSEcCtD
Mifepristone—Abdominal pain—Dactinomycin—testicular cancer	0.000305	0.00266	CcSEcCtD
Mifepristone—Fatigue—Ifosfamide—testicular cancer	0.000304	0.00266	CcSEcCtD
Mifepristone—Oedema—Cisplatin—testicular cancer	0.000304	0.00266	CcSEcCtD
Mifepristone—Hypersensitivity—Bleomycin—testicular cancer	0.000304	0.00266	CcSEcCtD
Mifepristone—Infection—Cisplatin—testicular cancer	0.000302	0.00264	CcSEcCtD
Mifepristone—Constipation—Ifosfamide—testicular cancer	0.000302	0.00264	CcSEcCtD
Mifepristone—Pain—Ifosfamide—testicular cancer	0.000302	0.00264	CcSEcCtD
Mifepristone—Hypoglycaemia—Doxorubicin—testicular cancer	0.000302	0.00263	CcSEcCtD
Mifepristone—Nervous system disorder—Cisplatin—testicular cancer	0.000299	0.00261	CcSEcCtD
Mifepristone—Asthenia—Bleomycin—testicular cancer	0.000296	0.00259	CcSEcCtD
Mifepristone—Skin disorder—Cisplatin—testicular cancer	0.000296	0.00258	CcSEcCtD
Mifepristone—Hypertension—Etoposide—testicular cancer	0.000295	0.00258	CcSEcCtD
Mifepristone—Pain in extremity—Doxorubicin—testicular cancer	0.000294	0.00257	CcSEcCtD
Mifepristone—Pruritus—Bleomycin—testicular cancer	0.000292	0.00255	CcSEcCtD
Mifepristone—Feeling abnormal—Ifosfamide—testicular cancer	0.000291	0.00254	CcSEcCtD
Mifepristone—Nausea—Vinblastine—testicular cancer	0.000291	0.00254	CcSEcCtD
Mifepristone—Anorexia—Cisplatin—testicular cancer	0.00029	0.00253	CcSEcCtD
Mifepristone—Hypokalaemia—Epirubicin—testicular cancer	0.000289	0.00253	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000289	0.00252	CcSEcCtD
Mifepristone—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000289	0.00252	CcSEcCtD
Mifepristone—Discomfort—Etoposide—testicular cancer	0.000287	0.00251	CcSEcCtD
Mifepristone—Breast disorder—Epirubicin—testicular cancer	0.000287	0.00251	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.000286	0.0025	CcSEcCtD
Mifepristone—Hypotension—Cisplatin—testicular cancer	0.000284	0.00248	CcSEcCtD
Mifepristone—Nasopharyngitis—Epirubicin—testicular cancer	0.000284	0.00248	CcSEcCtD
Mifepristone—Hypersensitivity—Dactinomycin—testicular cancer	0.000284	0.00248	CcSEcCtD
Mifepristone—ABCB1—lymph node—testicular cancer	0.000284	0.00292	CbGeAlD
Mifepristone—Muscular weakness—Epirubicin—testicular cancer	0.000281	0.00245	CcSEcCtD
Mifepristone—Urticaria—Ifosfamide—testicular cancer	0.000281	0.00245	CcSEcCtD
Mifepristone—Abdominal pain—Ifosfamide—testicular cancer	0.000279	0.00244	CcSEcCtD
Mifepristone—Body temperature increased—Ifosfamide—testicular cancer	0.000279	0.00244	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000277	0.00242	CcSEcCtD
Mifepristone—Infection—Etoposide—testicular cancer	0.000277	0.00242	CcSEcCtD
Mifepristone—Asthenia—Dactinomycin—testicular cancer	0.000276	0.00241	CcSEcCtD
Mifepristone—Dyspnoea—Cisplatin—testicular cancer	0.000271	0.00237	CcSEcCtD
Mifepristone—Skin disorder—Etoposide—testicular cancer	0.000271	0.00237	CcSEcCtD
Mifepristone—Hypokalaemia—Doxorubicin—testicular cancer	0.000268	0.00234	CcSEcCtD
Mifepristone—Breast disorder—Doxorubicin—testicular cancer	0.000266	0.00232	CcSEcCtD
Mifepristone—Anorexia—Etoposide—testicular cancer	0.000266	0.00232	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000265	0.00231	CcSEcCtD
Mifepristone—Decreased appetite—Cisplatin—testicular cancer	0.000265	0.00231	CcSEcCtD
Mifepristone—Diarrhoea—Dactinomycin—testicular cancer	0.000264	0.0023	CcSEcCtD
Mifepristone—Nasopharyngitis—Doxorubicin—testicular cancer	0.000263	0.0023	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000263	0.00229	CcSEcCtD
Mifepristone—Vomiting—Bleomycin—testicular cancer	0.000263	0.00229	CcSEcCtD
Mifepristone—Infestation—Methotrexate—testicular cancer	0.000262	0.00229	CcSEcCtD
Mifepristone—Infestation NOS—Methotrexate—testicular cancer	0.000262	0.00229	CcSEcCtD
Mifepristone—Hypotension—Etoposide—testicular cancer	0.000261	0.00228	CcSEcCtD
Mifepristone—Rash—Bleomycin—testicular cancer	0.000261	0.00227	CcSEcCtD
Mifepristone—Pain—Cisplatin—testicular cancer	0.00026	0.00227	CcSEcCtD
Mifepristone—Dermatitis—Bleomycin—testicular cancer	0.00026	0.00227	CcSEcCtD
Mifepristone—Hypersensitivity—Ifosfamide—testicular cancer	0.00026	0.00227	CcSEcCtD
Mifepristone—Muscular weakness—Doxorubicin—testicular cancer	0.00026	0.00227	CcSEcCtD
Mifepristone—Asthenia—Ifosfamide—testicular cancer	0.000253	0.00221	CcSEcCtD
Mifepristone—Feeling abnormal—Cisplatin—testicular cancer	0.000251	0.00219	CcSEcCtD
Mifepristone—Pruritus—Ifosfamide—testicular cancer	0.00025	0.00218	CcSEcCtD
Mifepristone—Dyspnoea—Etoposide—testicular cancer	0.000249	0.00217	CcSEcCtD
Mifepristone—Somnolence—Etoposide—testicular cancer	0.000248	0.00216	CcSEcCtD
Mifepristone—Nausea—Bleomycin—testicular cancer	0.000245	0.00214	CcSEcCtD
Mifepristone—Infestation NOS—Epirubicin—testicular cancer	0.000245	0.00214	CcSEcCtD
Mifepristone—Infestation—Epirubicin—testicular cancer	0.000245	0.00214	CcSEcCtD
Mifepristone—Vomiting—Dactinomycin—testicular cancer	0.000245	0.00214	CcSEcCtD
Mifepristone—Rash—Dactinomycin—testicular cancer	0.000243	0.00212	CcSEcCtD
Mifepristone—Decreased appetite—Etoposide—testicular cancer	0.000242	0.00212	CcSEcCtD
Mifepristone—Diarrhoea—Ifosfamide—testicular cancer	0.000242	0.00211	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Etoposide—testicular cancer	0.000241	0.0021	CcSEcCtD
Mifepristone—Body temperature increased—Cisplatin—testicular cancer	0.000241	0.0021	CcSEcCtD
Mifepristone—Fatigue—Etoposide—testicular cancer	0.00024	0.0021	CcSEcCtD
Mifepristone—Constipation—Etoposide—testicular cancer	0.000239	0.00208	CcSEcCtD
Mifepristone—Pain—Etoposide—testicular cancer	0.000239	0.00208	CcSEcCtD
Mifepristone—Haemoglobin—Methotrexate—testicular cancer	0.000236	0.00206	CcSEcCtD
Mifepristone—Haemorrhage—Methotrexate—testicular cancer	0.000235	0.00205	CcSEcCtD
Mifepristone—Dizziness—Ifosfamide—testicular cancer	0.000234	0.00204	CcSEcCtD
Mifepristone—Sinusitis—Epirubicin—testicular cancer	0.00023	0.00201	CcSEcCtD
Mifepristone—Feeling abnormal—Etoposide—testicular cancer	0.00023	0.00201	CcSEcCtD
Mifepristone—Nausea—Dactinomycin—testicular cancer	0.000229	0.002	CcSEcCtD
Mifepristone—Gastrointestinal pain—Etoposide—testicular cancer	0.000228	0.00199	CcSEcCtD
Mifepristone—Infestation—Doxorubicin—testicular cancer	0.000227	0.00198	CcSEcCtD
Mifepristone—Infestation NOS—Doxorubicin—testicular cancer	0.000227	0.00198	CcSEcCtD
Mifepristone—Vomiting—Ifosfamide—testicular cancer	0.000225	0.00196	CcSEcCtD
Mifepristone—Hypersensitivity—Cisplatin—testicular cancer	0.000224	0.00196	CcSEcCtD
Mifepristone—Rash—Ifosfamide—testicular cancer	0.000223	0.00194	CcSEcCtD
Mifepristone—Dermatitis—Ifosfamide—testicular cancer	0.000222	0.00194	CcSEcCtD
Mifepristone—Urticaria—Etoposide—testicular cancer	0.000222	0.00193	CcSEcCtD
Mifepristone—Haemoglobin—Epirubicin—testicular cancer	0.000221	0.00193	CcSEcCtD
Mifepristone—Abdominal pain—Etoposide—testicular cancer	0.00022	0.00192	CcSEcCtD
Mifepristone—Body temperature increased—Etoposide—testicular cancer	0.00022	0.00192	CcSEcCtD
Mifepristone—Haemorrhage—Epirubicin—testicular cancer	0.00022	0.00192	CcSEcCtD
Mifepristone—Asthenia—Cisplatin—testicular cancer	0.000218	0.00191	CcSEcCtD
Mifepristone—Oedema peripheral—Epirubicin—testicular cancer	0.000217	0.00189	CcSEcCtD
Mifepristone—Connective tissue disorder—Epirubicin—testicular cancer	0.000216	0.00189	CcSEcCtD
Mifepristone—Angiopathy—Methotrexate—testicular cancer	0.000213	0.00186	CcSEcCtD
Mifepristone—Sinusitis—Doxorubicin—testicular cancer	0.000213	0.00186	CcSEcCtD
Mifepristone—Mediastinal disorder—Methotrexate—testicular cancer	0.000212	0.00185	CcSEcCtD
Mifepristone—Chills—Methotrexate—testicular cancer	0.000211	0.00184	CcSEcCtD
Mifepristone—Nausea—Ifosfamide—testicular cancer	0.00021	0.00183	CcSEcCtD
Mifepristone—Diarrhoea—Cisplatin—testicular cancer	0.000208	0.00182	CcSEcCtD
Mifepristone—Mental disorder—Methotrexate—testicular cancer	0.000206	0.0018	CcSEcCtD
Mifepristone—Hypersensitivity—Etoposide—testicular cancer	0.000205	0.00179	CcSEcCtD
Mifepristone—Malnutrition—Methotrexate—testicular cancer	0.000205	0.00179	CcSEcCtD
Mifepristone—Haemoglobin—Doxorubicin—testicular cancer	0.000205	0.00179	CcSEcCtD
Mifepristone—Haemorrhage—Doxorubicin—testicular cancer	0.000204	0.00178	CcSEcCtD
Mifepristone—Oedema peripheral—Doxorubicin—testicular cancer	0.000201	0.00175	CcSEcCtD
Mifepristone—Asthenia—Etoposide—testicular cancer	0.0002	0.00175	CcSEcCtD
Mifepristone—Connective tissue disorder—Doxorubicin—testicular cancer	0.0002	0.00175	CcSEcCtD
Mifepristone—Angiopathy—Epirubicin—testicular cancer	0.0002	0.00174	CcSEcCtD
Mifepristone—Mediastinal disorder—Epirubicin—testicular cancer	0.000198	0.00173	CcSEcCtD
Mifepristone—Back pain—Methotrexate—testicular cancer	0.000198	0.00173	CcSEcCtD
Mifepristone—Chills—Epirubicin—testicular cancer	0.000197	0.00172	CcSEcCtD
Mifepristone—Pruritus—Etoposide—testicular cancer	0.000197	0.00172	CcSEcCtD
Mifepristone—Vomiting—Cisplatin—testicular cancer	0.000194	0.00169	CcSEcCtD
Mifepristone—Mental disorder—Epirubicin—testicular cancer	0.000193	0.00168	CcSEcCtD
Mifepristone—Rash—Cisplatin—testicular cancer	0.000192	0.00168	CcSEcCtD
Mifepristone—Dermatitis—Cisplatin—testicular cancer	0.000192	0.00167	CcSEcCtD
Mifepristone—Malnutrition—Epirubicin—testicular cancer	0.000192	0.00167	CcSEcCtD
Mifepristone—Diarrhoea—Etoposide—testicular cancer	0.000191	0.00167	CcSEcCtD
Mifepristone—Ill-defined disorder—Methotrexate—testicular cancer	0.00019	0.00166	CcSEcCtD
Mifepristone—Back pain—Epirubicin—testicular cancer	0.000185	0.00162	CcSEcCtD
Mifepristone—Angiopathy—Doxorubicin—testicular cancer	0.000185	0.00161	CcSEcCtD
Mifepristone—Malaise—Methotrexate—testicular cancer	0.000185	0.00161	CcSEcCtD
Mifepristone—Dizziness—Etoposide—testicular cancer	0.000184	0.00161	CcSEcCtD
Mifepristone—Muscle spasms—Epirubicin—testicular cancer	0.000184	0.00161	CcSEcCtD
Mifepristone—Mediastinal disorder—Doxorubicin—testicular cancer	0.000184	0.0016	CcSEcCtD
Mifepristone—Chills—Doxorubicin—testicular cancer	0.000183	0.0016	CcSEcCtD
Mifepristone—Nausea—Cisplatin—testicular cancer	0.000181	0.00158	CcSEcCtD
Mifepristone—Mental disorder—Doxorubicin—testicular cancer	0.000178	0.00156	CcSEcCtD
Mifepristone—Ill-defined disorder—Epirubicin—testicular cancer	0.000178	0.00155	CcSEcCtD
Mifepristone—Vomiting—Etoposide—testicular cancer	0.000177	0.00155	CcSEcCtD
Mifepristone—Malnutrition—Doxorubicin—testicular cancer	0.000177	0.00155	CcSEcCtD
Mifepristone—Rash—Etoposide—testicular cancer	0.000176	0.00154	CcSEcCtD
Mifepristone—Dermatitis—Etoposide—testicular cancer	0.000176	0.00153	CcSEcCtD
Mifepristone—Headache—Etoposide—testicular cancer	0.000175	0.00153	CcSEcCtD
Mifepristone—Myalgia—Methotrexate—testicular cancer	0.000174	0.00152	CcSEcCtD
Mifepristone—Arthralgia—Methotrexate—testicular cancer	0.000174	0.00152	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000173	0.00151	CcSEcCtD
Mifepristone—Malaise—Epirubicin—testicular cancer	0.000173	0.00151	CcSEcCtD
Mifepristone—Discomfort—Methotrexate—testicular cancer	0.000172	0.0015	CcSEcCtD
Mifepristone—Back pain—Doxorubicin—testicular cancer	0.000171	0.0015	CcSEcCtD
Mifepristone—Muscle spasms—Doxorubicin—testicular cancer	0.00017	0.00149	CcSEcCtD
Mifepristone—Infection—Methotrexate—testicular cancer	0.000166	0.00145	CcSEcCtD
Mifepristone—Nausea—Etoposide—testicular cancer	0.000166	0.00145	CcSEcCtD
Mifepristone—Hypertension—Epirubicin—testicular cancer	0.000165	0.00144	CcSEcCtD
Mifepristone—Ill-defined disorder—Doxorubicin—testicular cancer	0.000164	0.00144	CcSEcCtD
Mifepristone—Nervous system disorder—Methotrexate—testicular cancer	0.000164	0.00143	CcSEcCtD
Mifepristone—Arthralgia—Epirubicin—testicular cancer	0.000163	0.00142	CcSEcCtD
Mifepristone—Myalgia—Epirubicin—testicular cancer	0.000163	0.00142	CcSEcCtD
Mifepristone—Anxiety—Epirubicin—testicular cancer	0.000163	0.00142	CcSEcCtD
Mifepristone—Skin disorder—Methotrexate—testicular cancer	0.000162	0.00142	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000162	0.00141	CcSEcCtD
Mifepristone—Discomfort—Epirubicin—testicular cancer	0.000161	0.00141	CcSEcCtD
Mifepristone—Malaise—Doxorubicin—testicular cancer	0.00016	0.0014	CcSEcCtD
Mifepristone—Dry mouth—Epirubicin—testicular cancer	0.000159	0.00139	CcSEcCtD
Mifepristone—Anorexia—Methotrexate—testicular cancer	0.000159	0.00139	CcSEcCtD
Mifepristone—Oedema—Epirubicin—testicular cancer	0.000156	0.00136	CcSEcCtD
Mifepristone—Hypotension—Methotrexate—testicular cancer	0.000156	0.00136	CcSEcCtD
Mifepristone—Infection—Epirubicin—testicular cancer	0.000155	0.00136	CcSEcCtD
Mifepristone—Nervous system disorder—Epirubicin—testicular cancer	0.000153	0.00134	CcSEcCtD
Mifepristone—Hypertension—Doxorubicin—testicular cancer	0.000153	0.00134	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000152	0.00133	CcSEcCtD
Mifepristone—Skin disorder—Epirubicin—testicular cancer	0.000152	0.00133	CcSEcCtD
Mifepristone—Insomnia—Methotrexate—testicular cancer	0.000151	0.00132	CcSEcCtD
Mifepristone—Arthralgia—Doxorubicin—testicular cancer	0.000151	0.00132	CcSEcCtD
Mifepristone—Myalgia—Doxorubicin—testicular cancer	0.000151	0.00132	CcSEcCtD
Mifepristone—Anxiety—Doxorubicin—testicular cancer	0.00015	0.00131	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00015	0.00131	CcSEcCtD
Mifepristone—Discomfort—Doxorubicin—testicular cancer	0.000149	0.0013	CcSEcCtD
Mifepristone—Anorexia—Epirubicin—testicular cancer	0.000149	0.0013	CcSEcCtD
Mifepristone—Dyspnoea—Methotrexate—testicular cancer	0.000149	0.0013	CcSEcCtD
Mifepristone—Somnolence—Methotrexate—testicular cancer	0.000149	0.0013	CcSEcCtD
Mifepristone—Dry mouth—Doxorubicin—testicular cancer	0.000148	0.00129	CcSEcCtD
Mifepristone—Hypotension—Epirubicin—testicular cancer	0.000146	0.00128	CcSEcCtD
Mifepristone—Decreased appetite—Methotrexate—testicular cancer	0.000145	0.00127	CcSEcCtD
Mifepristone—Oedema—Doxorubicin—testicular cancer	0.000145	0.00126	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000144	0.00126	CcSEcCtD
Mifepristone—Fatigue—Methotrexate—testicular cancer	0.000144	0.00126	CcSEcCtD
Mifepristone—Infection—Doxorubicin—testicular cancer	0.000144	0.00125	CcSEcCtD
Mifepristone—Pain—Methotrexate—testicular cancer	0.000143	0.00125	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000142	0.00124	CcSEcCtD
Mifepristone—Nervous system disorder—Doxorubicin—testicular cancer	0.000142	0.00124	CcSEcCtD
Mifepristone—Insomnia—Epirubicin—testicular cancer	0.000141	0.00123	CcSEcCtD
Mifepristone—Skin disorder—Doxorubicin—testicular cancer	0.000141	0.00123	CcSEcCtD
Mifepristone—Dyspnoea—Epirubicin—testicular cancer	0.000139	0.00122	CcSEcCtD
Mifepristone—Somnolence—Epirubicin—testicular cancer	0.000139	0.00121	CcSEcCtD
Mifepristone—Anorexia—Doxorubicin—testicular cancer	0.000138	0.0012	CcSEcCtD
Mifepristone—Feeling abnormal—Methotrexate—testicular cancer	0.000138	0.0012	CcSEcCtD
Mifepristone—Gastrointestinal pain—Methotrexate—testicular cancer	0.000137	0.00119	CcSEcCtD
Mifepristone—Decreased appetite—Epirubicin—testicular cancer	0.000136	0.00119	CcSEcCtD
Mifepristone—Hypotension—Doxorubicin—testicular cancer	0.000135	0.00118	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000135	0.00118	CcSEcCtD
Mifepristone—Fatigue—Epirubicin—testicular cancer	0.000135	0.00118	CcSEcCtD
Mifepristone—Pain—Epirubicin—testicular cancer	0.000134	0.00117	CcSEcCtD
Mifepristone—Constipation—Epirubicin—testicular cancer	0.000134	0.00117	CcSEcCtD
Mifepristone—Urticaria—Methotrexate—testicular cancer	0.000133	0.00116	CcSEcCtD
Mifepristone—Abdominal pain—Methotrexate—testicular cancer	0.000132	0.00115	CcSEcCtD
Mifepristone—Body temperature increased—Methotrexate—testicular cancer	0.000132	0.00115	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000132	0.00115	CcSEcCtD
Mifepristone—Insomnia—Doxorubicin—testicular cancer	0.000131	0.00114	CcSEcCtD
Mifepristone—Dyspnoea—Doxorubicin—testicular cancer	0.000129	0.00113	CcSEcCtD
Mifepristone—Feeling abnormal—Epirubicin—testicular cancer	0.000129	0.00112	CcSEcCtD
Mifepristone—Somnolence—Doxorubicin—testicular cancer	0.000129	0.00112	CcSEcCtD
Mifepristone—Gastrointestinal pain—Epirubicin—testicular cancer	0.000128	0.00112	CcSEcCtD
Mifepristone—Decreased appetite—Doxorubicin—testicular cancer	0.000126	0.0011	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000125	0.00109	CcSEcCtD
Mifepristone—Fatigue—Doxorubicin—testicular cancer	0.000125	0.00109	CcSEcCtD
Mifepristone—Urticaria—Epirubicin—testicular cancer	0.000124	0.00108	CcSEcCtD
Mifepristone—Constipation—Doxorubicin—testicular cancer	0.000124	0.00108	CcSEcCtD
Mifepristone—Pain—Doxorubicin—testicular cancer	0.000124	0.00108	CcSEcCtD
Mifepristone—Abdominal pain—Epirubicin—testicular cancer	0.000124	0.00108	CcSEcCtD
Mifepristone—Body temperature increased—Epirubicin—testicular cancer	0.000124	0.00108	CcSEcCtD
Mifepristone—Hypersensitivity—Methotrexate—testicular cancer	0.000123	0.00107	CcSEcCtD
Mifepristone—Asthenia—Methotrexate—testicular cancer	0.00012	0.00105	CcSEcCtD
Mifepristone—Feeling abnormal—Doxorubicin—testicular cancer	0.000119	0.00104	CcSEcCtD
Mifepristone—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000118	0.00103	CcSEcCtD
Mifepristone—Pruritus—Methotrexate—testicular cancer	0.000118	0.00103	CcSEcCtD
Mifepristone—Hypersensitivity—Epirubicin—testicular cancer	0.000115	0.00101	CcSEcCtD
Mifepristone—Urticaria—Doxorubicin—testicular cancer	0.000115	0.001	CcSEcCtD
Mifepristone—Body temperature increased—Doxorubicin—testicular cancer	0.000114	0.000998	CcSEcCtD
Mifepristone—Abdominal pain—Doxorubicin—testicular cancer	0.000114	0.000998	CcSEcCtD
Mifepristone—Diarrhoea—Methotrexate—testicular cancer	0.000114	0.000998	CcSEcCtD
Mifepristone—Asthenia—Epirubicin—testicular cancer	0.000112	0.000979	CcSEcCtD
Mifepristone—Pruritus—Epirubicin—testicular cancer	0.000111	0.000966	CcSEcCtD
Mifepristone—Dizziness—Methotrexate—testicular cancer	0.00011	0.000964	CcSEcCtD
Mifepristone—Diarrhoea—Epirubicin—testicular cancer	0.000107	0.000934	CcSEcCtD
Mifepristone—Hypersensitivity—Doxorubicin—testicular cancer	0.000107	0.00093	CcSEcCtD
Mifepristone—Vomiting—Methotrexate—testicular cancer	0.000106	0.000927	CcSEcCtD
Mifepristone—Rash—Methotrexate—testicular cancer	0.000105	0.00092	CcSEcCtD
Mifepristone—Dermatitis—Methotrexate—testicular cancer	0.000105	0.000919	CcSEcCtD
Mifepristone—Headache—Methotrexate—testicular cancer	0.000105	0.000914	CcSEcCtD
Mifepristone—Asthenia—Doxorubicin—testicular cancer	0.000104	0.000906	CcSEcCtD
Mifepristone—Dizziness—Epirubicin—testicular cancer	0.000103	0.000903	CcSEcCtD
Mifepristone—Pruritus—Doxorubicin—testicular cancer	0.000102	0.000894	CcSEcCtD
Mifepristone—Vomiting—Epirubicin—testicular cancer	9.94e-05	0.000868	CcSEcCtD
Mifepristone—Nausea—Methotrexate—testicular cancer	9.92e-05	0.000866	CcSEcCtD
Mifepristone—Diarrhoea—Doxorubicin—testicular cancer	9.9e-05	0.000864	CcSEcCtD
Mifepristone—Rash—Epirubicin—testicular cancer	9.86e-05	0.000861	CcSEcCtD
Mifepristone—Dermatitis—Epirubicin—testicular cancer	9.85e-05	0.00086	CcSEcCtD
Mifepristone—Headache—Epirubicin—testicular cancer	9.79e-05	0.000855	CcSEcCtD
Mifepristone—Dizziness—Doxorubicin—testicular cancer	9.57e-05	0.000835	CcSEcCtD
Mifepristone—Nausea—Epirubicin—testicular cancer	9.29e-05	0.000811	CcSEcCtD
Mifepristone—Vomiting—Doxorubicin—testicular cancer	9.2e-05	0.000803	CcSEcCtD
Mifepristone—Rash—Doxorubicin—testicular cancer	9.12e-05	0.000796	CcSEcCtD
Mifepristone—Dermatitis—Doxorubicin—testicular cancer	9.11e-05	0.000796	CcSEcCtD
Mifepristone—Headache—Doxorubicin—testicular cancer	9.06e-05	0.000791	CcSEcCtD
Mifepristone—Nausea—Doxorubicin—testicular cancer	8.59e-05	0.00075	CcSEcCtD
